Tai Chi for Insomnia in Breast Cancer Survivors
Trial Summary
What is the purpose of this trial?
Breast Cancer is the most common cancer in women. After completion of successful therapy, may behavioral symptoms persist with over 20% of breast cancer survivors reporting chronic insomnia of greater than 6 months duration that fulfils clinical diagnostic criteria with associated functional limitations, decreased quality of life, and possible effects on long-term survival. Behavioral interventions are highly efficacious in the treatment of insomnia and preferred over hypnotic medication when insomnia is chronic. However, insomnia studies conducted in cancer are scarce. The proposed research builds upon program of study that has examined the efficacy of mind-body intervention, Tai Chi Chih (TCC), on health outcomes including sleep impairments. Preliminary studies show that TTC, a slow moving meditation, contributes to improvement in subjective sleep quality, sleep amounts and sleep efficiency. The investigators have further found that sleep, fatigue and proinflammatory cytokine activity are reciprocally related and that TCC decreases the mechanism through TCC carries its effects on sleep outcomes.
Research Team
Michael Irwin, MD
Principal Investigator
University of California, Los Angeles
Eligibility Criteria
This trial is for postmenopausal women aged 30-70 who had early-stage breast cancer, have finished treatment, and are now struggling with chronic insomnia. They should experience sleep difficulties at least three nights a week for over six months and live close enough to attend sessions. Exclusions include those with certain medical conditions affecting sleep or immune function, obesity (BMI >35), smokers, cognitive impairment, other major psychiatric disorders or different sleep disorders.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Cognitive Behavioral Therapy (Behavioral Intervention)
- Tai Chi Chih (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Jonsson Comprehensive Cancer Center
Lead Sponsor
Dr. Aparna Bhaduri
Jonsson Comprehensive Cancer Center
Chief Medical Officer since 2024
MD
Dr. Michael A. Teitell
Jonsson Comprehensive Cancer Center
Chief Executive Officer since 2024
MD, PhD
National Center for Research Resources (NCRR)
Collaborator
Barbara M. Alving
National Center for Research Resources (NCRR)
Chief Executive Officer since 2005
MD from Georgetown University School of Medicine
Lawrence A. Tabak
National Center for Research Resources (NCRR)
Chief Medical Officer since 2009
MD from University of Pennsylvania